Navamedic ASA (0FDB) Stock Statistics & Valuation Metrics
Total Valuation
Navamedic ASA has a market cap or net worth of NOK 267.39M. The enterprise value is NOK 463.99M.
- Market Cap
- NOK 267.39M
- Enterprise Value
- NOK 463.99M
Share Statistics
Navamedic ASA has 23,981,379 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 23,981,379
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Navamedic ASA’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 1.55%.
- Return on Equity (ROE)
- 0.01
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 1.55%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 13.99M
- Profits Per Employee
- 33.95K
- Employee Count
- 38
- Asset Turnover
- 1.08
- Inventory Turnover
- 3.94
Valuation Ratios
The current PE Ratio of Navamedic ASA is 315.26. Navamedic ASA’s PEG ratio is -3.41.
- PE Ratio
- 315.26
- PS Ratio
- 0.76
- PB Ratio
- 1.69
- Price to FCF
- -20.66
- Price to Operating Cash Flow
- -22.65
- PEG Ratio
- -3.41
Income Statement
In the last 12 months, Navamedic ASA had revenue of 531.44M and earned 1.29M in profits. Earnings per share was 0.07.
- Revenue
- 531.44M
- Gross Profit
- 208.88M
- Operating Income
- 24.13M
- Pretax Income
- 5.16M
- Net Income
- 1.29M
- EBITDA
- 46.55M
- Earnings Per Share (EPS)
- 0.07
Cash Flow
In the last 12 months, operating cash flow was 9.28M and capital expenditures -247,000, giving a free cash flow of 9.03M billion.
- Operating Cash Flow
- 9.28M
- Free Cash Flow
- 9.03M
- Free Cash Flow per Share
- -1.11
Dividends & Yields
Navamedic ASA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.84%
- Earnings Yield
- 0.32%
Stock Price Statistics
- Beta
- -0.02
- 52-Week Price Change
- -49.09%
- 50-Day Moving Average
- 14.11
- 200-Day Moving Average
- 19.29
- Relative Strength Index (RSI)
- 29.64
- Average Volume (3m)
- 420
Important Dates
Navamedic ASA upcoming earnings date is Feb 12, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 12, 2027
- Ex-Dividend Date
- ―
Financial Position
Navamedic ASA as a current ratio of 1.42, with Debt / Equity ratio of 58.20%
- Current Ratio
- 1.42
- Quick Ratio
- 0.84
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- 2.21
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Navamedic ASA has paid 3.87M in taxes.
- Income Tax
- 3.87M
- Effective Tax Rate
- 0.75
Enterprise Valuation
Navamedic ASA EV to EBITDA ratio is 10.93, with an EV/FCF ratio of -25.88.
- EV to Sales
- 0.96
- EV to EBITDA
- 10.93
- EV to Free Cash Flow
- -25.88
- EV to Operating Cash Flow
- -28.31
Balance Sheet
Navamedic ASA has NOK 53.48M in cash and marketable securities with NOK 139.93M in debt, giving a net cash position of -NOK 86.45M billion.
- Cash & Marketable Securities
- NOK 53.48M
- Total Debt
- NOK 139.93M
- Net Cash
- -NOK 86.45M
- Net Cash Per Share
- -NOK 3.61
- Tangible Book Value Per Share
- -NOK 0.63
Margins
Gross margin is 34.79%, with operating margin of 4.54%, and net profit margin of 0.24%.
- Gross Margin
- 34.79%
- Operating Margin
- 4.54%
- Pretax Margin
- 0.97%
- Net Profit Margin
- 0.24%
- EBITDA Margin
- 8.76%
- EBIT Margin
- 5.98%
Analyst Forecast
The average price target for Navamedic ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 3.08%
- EPS Growth Forecast
- 41.25%
